Your calculated prostate volume provides an estimate of gland size based on the prolate ellipsoid formula. A volume under 30 mL is generally considered normal for an adult male. A volume of 30 to 59 mL indicates mild enlargement, which is common with age and may or may not be associated with significant urinary symptoms. A volume of 60 to 99 mL represents moderate enlargement that is more likely to cause obstructive symptoms and may influence treatment selection. A volume of 100 mL or greater indicates severe enlargement and typically requires consideration of surgical approaches suited to very large glands.

Prostate volume is a key input for calculating PSA density, which helps differentiate elevated PSA due to benign hyperplasia from that caused by prostate cancer. Larger prostates naturally produce more PSA from benign epithelial tissue, so a man with a 80 mL prostate and a PSA of 6 ng/mL has a very different risk profile than a man with a 25 mL prostate and the same PSA level.

Prostate volume calculation is indicated whenever prostate size is needed for clinical decision-making. Common scenarios include calculating PSA density during prostate cancer workup, planning surgical approach for BPH treatment (TURP is typically suitable for glands up to 80 mL, while HoLEP or open prostatectomy may be preferred for larger glands), and assessing eligibility for minimally invasive procedures such as UroLift (generally limited to glands of 80 mL or less without a prominent median lobe).

Volume measurement is also used in active surveillance protocols for low-risk prostate cancer, where increasing prostate size over time may affect PSA density trends. In radiation oncology, accurate volume assessment helps with treatment planning for brachytherapy seed placement.

The ellipsoid formula assumes the prostate approximates an ellipsoid shape, which is a simplification. Prostates with prominent median lobes, irregular contours, or asymmetric enlargement may not be accurately represented by this formula. In such cases, planimetric volume calculation from MRI (summing cross-sectional areas across all slices) provides a more precise measurement.

Measurement accuracy depends on the imaging modality and operator skill. Transrectal ultrasound measurements have interobserver variability of 10 to 20%, and small errors in any of the three dimensions are magnified by the multiplication in the formula. MRI-based measurements are more reproducible but require dedicated imaging.

Prostate volume alone does not predict symptom severity. Some men with significantly enlarged prostates have minimal urinary symptoms, while others with only mildly enlarged glands experience severe obstruction due to median lobe anatomy or detrusor dysfunction. Volume should always be interpreted alongside symptom assessment (IPSS), flow studies, and post-void residual measurement.